A novel CEP290 disease-causing variant identified in a patient with leber congenital amaurosis using a medical diagnostic panel sequencing

References

• Den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27(4):391–419.
   PubMed Web of Science ®Google Scholar
• Tsang SH, Sharma T. Leber congenital amaurosis. In: Tsang SH, Sharma T, editors. Atlas of inherited retinal diseases. Cham: Springer International Publishing; 2018. p. 131–37.
   Google Scholar
• Shimada H, Lu Q, Insinna-Kettenhofen C, Nagashima K, English MA, Semler EM, Mahgerefteh J, Cideciyan AV, Li T, Brooks BP, et al. In Vitro modeling using ciliopathy-patient-derived cells reveals distinct cilia dysfunctions caused by CEP290 mutations. Cell Rep. 2017;20(2):384–96. doi:10.1016/j.celrep.2017.06.045.
   PubMedGoogle Scholar
• Rachel RA, Yamamoto EA, Dewanjee MK, May-Simera HL, Sergeev YV, Hackett AN, Pohida K, Munasinghe J, Gotoh N, Wickstead B, et al. CEP290 alleles in mice disrupt tissue-specific cilia biogenesis and recapitulate features of syndromic ciliopathies. Hum Mol Genet. 2015;24(13):3775–91. doi:10.1093/hmg/ddv123.
   PubMed Web of Science ®Google Scholar
• Gilliam JC, Chang JT, Sandoval IM, Zhang Y, Li T, Pittler SJ, Chiu W, Wensel T. Three-dimensional architecture of the rod sensory cilium and its disruption in retinal neurodegeneration. Cell. 2012;151(5):1029–41. doi:10.1016/j.cell.2012.10.038.
   PubMedGoogle Scholar
• Marszalek JR, Liu X, Roberts EA, Chui D, Marth JD, Williams DS, Goldstein LSB. Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell. 2000;102(2):175–87. doi:10.1016/S0092-8674(00)00023-4.
   PubMed Web of Science ®Google Scholar
• Perrault I, Delphin N, Hanein S, Gerber S, Dufier JL, Roche O, Defoort-Dhellemmes S, Dollfus H, Fazzi E, Munnich A, et al. Spectrum of NPHP6/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype. Hum Mutat. 2007;28(4):416. doi:10.1002/humu.9485.
   PubMedGoogle Scholar
• Russell SR, Drack AV, Cideciyan AV, Jacobson SG, Leroy BP, Pfeifer WL, Dumitrescu AV, Garafolo AV, Ho AC, Van Cauwenbergh C, De Zaeytijd J Results of a phase 1b/2 trial of intravitreal (IVT) sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis 10 (LCA10) due to p.Cys998X mutation in the CEP290 gene. Invest Ophthalmol Vis Sci. 2020;61:ARVO E–Abstract 866.
   Web of Science ®Google Scholar
• Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118(1):69–77. doi:10.1007/s10633-008-9155-4.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Den Hollander AI, Koenekoop RK, Yzer S, Lopez I, Arends ML, Voesenek KE, Zonneveld MN, Strom TM, Meitinger T, Brunner HG, et al. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am J Hum Genet. 2006;79(3):556–61. doi:10.1086/507318.
   PubMed Web of Science ®Google Scholar
• Sheck L, Davies WIL, Moradi P, Robson AG, Kumaran N, Liasis AC, Webster AR, Moore AT, Michaelides M. Leber congenital amaurosis associated with mutations in CEP290, clinical phenotype, and natural history in preparation for trials of novel therapies. Ophthalmology. 2018;125(6):894–903. doi:10.1016/j.ophtha.2017.12.013.
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Sumaroka A, Roman AJ, Charng J, Lu M, Choi W, Sheplock R, Swider M, Kosyk MS, et al. Outcome measures for clinical trials of leber congenital amaurosis caused by the intronic mutation in the CEP290 Gene. Invest Ophthalmol Vis Sci. 2017;58(5):2609–22. doi:10.1167/iovs.17-21560.
   PubMed Web of Science ®Google Scholar
• Pasadhika S, Fishman GA, Stone EM, Lindeman M, Zelkha R, Lopez I, Koenekoop RK, Shahidi M. Differential macular morphology in patients with RPE65-, CEP290-CEP290-, GUCY2D-GUCY2D-, and AIPL1-related AIPL1-related leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2010;51(5):2608–14. doi:10.1167/iovs.09-3734.
   PubMedGoogle Scholar
• Moradi P, Davies WL, Mackay DS, Cheetham ME, Moore AT. Focus on molecules: centrosomal protein 290 (CEP290). Exp Eye Res. 2011;92(5):316–17. doi:10.1016/j.exer.2010.05.009.
   PubMed Web of Science ®Google Scholar
• Burnight ER, Wiley LA, Drack AV, Braun TA, Anfinson KR, Kaalberg EE, Halder JA, Affatigato LM, Mullins RF, Stone EM, et al. CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype. Gene Ther. 2014;21(7):662–72. doi:10.1038/gt.2014.39.
   PubMed Web of Science ®Google Scholar
• Kilander MBC, Wang CH, Chang CH, Nestor JE, Herold K, Tsai JW, Nestor MW, Lin Y-C. A rare human CEP290 variant disrupts the molecular integrity of the primary cilium and impairs Sonic Hedgehog machinery. Sci Rep. 2018;8(1):17335. doi:10.1038/s41598-018-35614-x.
   PubMedGoogle Scholar
• Wang X, Wang H, Sun V, Tuan HF, Keser V, Wang K, Ren H, Lopez I, Zaneveld JE, Siddiqui S, et al. Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing. J Med Genet. 2013;50(10):674–88. doi:10.1136/jmedgenet-2013-101558.
   PubMed Web of Science ®Google Scholar
• Bachmann-Gagescu R, Dempsey JC, Phelps IG, O’Roak BJ, Knutzen DM, Rue TC, Ishak GE, Isabella CR, Gorden N, Adkins J, et al. Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity. J Med Genet. 2015;52(8):514–22. doi:10.1136/jmedgenet-2015-103087.
   PubMed Web of Science ®Google Scholar
• Baker KE, Parker R. Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol. 2004;16(3):293–99. doi:10.1016/j.ceb.2004.03.003.
   PubMed Web of Science ®Google Scholar
• Molinari E, Srivastava S, Sayer JA, Ramsbottom SA. From disease modelling to personalised therapy in patients with CEP290 mutations. F1000Res. 2017;6:669. doi:10.12688/f1000research.11553.1.
   PubMedGoogle Scholar
• Drivas TG, Wojno AP, Tucker BA, Stone EM, Bennett J. Basal exon skipping and genetic pleiotropy: a predictive model of disease pathogenesis. Sci Transl Med. 2015;7(291):291ra97. doi:10.1126/scitranslmed.aaa5370.
   PubMed Web of Science ®Google Scholar